vVARDIS HOLDING AG Class A
vVARDIS HOLDING AG Class A
Your view on VVVV
Overview
What the company does, where it operates, and who runs it.
About vVARDIS HOLDING AG Class A
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Goly Abivardi
- Headquarters
- Gubelstrasse 24, Zug, ZG, CH
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Goly Abivardi
- Headquarters
- Gubelstrasse 24, Zug, ZG, CH
vVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States.
The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel.
The company was incorporated in 2020 and is based in Zug, Switzerland. vVARDIS Holding AG operates as a subsidiary of VVARDIS Investment Holding AG.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for vVARDIS HOLDING AG Class A from FRC's valuation model, read against the market price. VVVV last traded at $15.47; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for vVARDIS HOLDING AG Class A. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for vVARDIS HOLDING AG Class A. vVARDIS HOLDING AG Class A does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for vVARDIS HOLDING AG Class A. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for vVARDIS HOLDING AG Class A. vVARDIS HOLDING AG Class A has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
More Medical - Specialties companies
Market cap
- ACAISafeplus International Holdings LimitedOTC$477
- ADLIAmerican Medical Technologies Inc.OTC$1,031
- AIMVAI Maverick Intel, Inc.OTC$3M
- ALCAlcon Inc.NYSE$36.2B
- ANIKAnika Therapeutics, Inc.NASDAQ$182M
- APYXApyx Medical CorporationNASDAQ$105M
- ASFXAmerican Scientific Resources, IncorporatedOTC$7,001
- AVTIAvitar, Inc.OTC$1,382
- BEATHeartBeam, Inc.NASDAQ$22M
- BEATWHeartBeam, Inc.NASDAQ$7M
- BIELBioElectronics CorporationOTC$7M
- BMGPBiomagnetics Diagnostics Corp.OTC$1,265
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold vVARDIS HOLDING AG Class A, and how their positions are changing. At a $597.1M market value, institutional positions materially move vVARDIS HOLDING AG Class A's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by vVARDIS HOLDING AG Class A executives and directors. Shares of vVARDIS HOLDING AG Class A have traded between $14.00 and $18.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming vVARDIS HOLDING AG Class A. vVARDIS HOLDING AG Class A is a $597.1M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming vVARDIS HOLDING AG Class A. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for vVARDIS HOLDING AG Class A. Coverage tracks vVARDIS HOLDING AG Class A within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of vVARDIS HOLDING AG Class A.